Company Overview

Development Stage

About the Company

Hubei Tianqin Biotechnology Co., Ltd. was established in 2009, with its headquarters located in Biolake, East Lake High-tech Development Zone, Wuhan. It is a CRO high-tech enterprise characterized by large animal testing and focused on preclinical research and evaluation of new drugs. The company has passed GLP certification, CNAS certification, and international AAALAC certification. It is the primate reproductive and developmental toxicity research platform in China of the WHO Collaborating Centre for Human Reproduction Research, the drug safety evaluation demonstration platform of the National Science and Technology Major Project for Major New Drug Innovation of the Ministry of Science and Technology, and a national pilot unit for strategic emerging industry clusters.

Adhering to its corporate mission of "serving pharmaceutical innovation and dedicating to life and health," Tianqin Bio relies on core experimental large animal resources to build business forms including experimental large animal breeding, construction of high-end large animal disease models, non-clinical CRO drug services, physician training, and scientific research services. Centering on high-quality experimental large animal resources and R&D technology platforms, it continuously deepens and expands its business areas, aiming to become the most trusted partner of global pharmaceutical innovators. At present, it has successfully established six major technology service platforms: non-human primate experimental animal breeding, human disease animal models, drug toxicity research and safety evaluation, pharmacokinetics and pharmacodynamics research and evaluation, molecular imaging labeling and detection, and bioanalysis. It has more than 20,000 square meters of GLP-compliant laboratories, capable of conducting experimental research based on monkeys, dogs, rabbits, rats, mice, guinea pigs, and other experimental animals. The laboratory area of the planned Tianqin Bio Industrial Park will exceed 100,000 square meters.

In the future, Tianqin Bio will be committed to building an integrated industry-university-research public service platform for large animal testing, becoming a domestically first-class and internationally renowned comprehensive CRO service enterprise for drug research and evaluation.


Honors and Qualifications

China GLP (State Food and Drug Administration)

Certification CNAS (China National Accreditation Service for Conformity Assessment)

Certification AAALAC (Association for Assessment and Accreditation of Laboratory Animal Care International)

Certification Drug Non-clinical Research and Safety Evaluation Hubei Provincial Engineering Research Center

Wuhan National Bio-industry Base Public Service Platform

National Strategic Emerging Industry Cluster Pilot Unit

Hubei Non-human Primate Reproductive and Developmental Toxicology Research Platform

Hubei Non-human Primate Animal Breeding Research Base

Vice-chairman Unit of Hubei Society for Laboratory Animal Science

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Tianqin Bio How Fast Is Hiring Growing? (80 open positions)

Manage
Note: How fast is hiring at Hubei Tianqin Biotechnology Group Co., Ltd. growing? Tianqin Bio2026: 141 openings (up 27%), 2025: 111 openings (up 79%), 2024: 62 openings (down 35%), 2023: 96 openings (up 63%), 2022: 59 openings (down 57%), 2021: 137 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Tianqin Bio Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Up 80%
  • 2024: Down 77%
  • 2023: Up 175%
  • 2022: Flat 0%-
Tianqin Bio Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at Hubei Tianqin Biotechnology Group Co., Ltd. growing? Tianqin BioMaster's recruitment over the years: 2025: 9 openings (up 80%), 2024: 5 openings (down 77%), 2023: 22 openings (up 175%), 2022: 8 openings (flat), 2021: 8 openings.

Tianqin Bio Doctoral Degree Job Demand Analysis

(More)
N/A
Growth Rate
Tianqin Bio Doctoral Hiring by Year: 2022 — same as 2021
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at Hubei Tianqin Biotechnology Group Co., Ltd. growing? Tianqin BioDoctorate recruitment over the years: 2022: 1 openings (flat), 2021: 1 openings.

Tianqin Bio R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Hubei Tianqin Biotechnology Group Co., Ltd.? Based on an analysis of Tianqin Bio's job postings over the past year, "医疗卫生/美容保健类" demand: 31.8%, "生物/制药/化工/环保类": 18.8%, "其他(研发和技术类)": 6.3%, "农林渔类": 3.1%, "科研类": 2.6%, "计算机/网络/技术类": 2.1%. For reference only.

Tianqin Bio — What Are the Salaries Like? (192 records)

Manage
salary range: 3K - 30K, 68.8% of roles pay ¥6-15K
Note: salary statistics are based on 192 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Hubei Tianqin Biotechnology Group Co., Ltd.?Tianqin Bio68.8% of positions earn 6-15K, Fresh graduate salary: ¥3.1K。医疗卫生/美容保健类 average salary ¥10.1K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of Tianqin Bio

(More)
Are salaries high at Hubei Tianqin Biotechnology Group Co., Ltd.? We provide: 兽医,分析,实习生,sd,实验员,档案管理,检测,行政,qa,专题负责人,病理技术员,质量,bd,前台,影像,研究员,部长,采购,饲养员,qc. Click to view detailed salary analysis by job.

Tianqin Bio Related Industry Tags

Job Category

  • 医疗卫生/美容保健类
    33.5% of total 33.5%
  • 工厂生产类
    21.3% of total 21.3%
  • 质量管理类
    19.8% of total 19.8%
  • 生物/制药/化工/环保类
    18.3% of total 18.3%

Education

  • 本科
    46.2% of total 46.2%
  • 大专
    29.9% of total 29.9%
  • 硕士
    16.2% of total 16.2%
  • 不限
    6.6% of total 6.6%

Experience

  • 1-3年
    35% of total 35%
  • 不限
    33% of total 33%
  • 3-5年
    21.3% of total 21.3%
  • 5-10年
    9.6% of total 9.6%
View Detailed Analysis

What does Hubei Tianqin Biotechnology Group Co., Ltd. require? Who is Tianqin Bio hiring? Tianqin Bio recruitment: 医疗卫生/美容保健类占比最多占33.5%,其次是工厂生产类占21.3%. What education can get in at Tianqin Bio? 本科占比最多占46.2%,其次是大专占29.9%. High education required at Tianqin Bio? 硕士占16.2%. Work experience required at Tianqin Bio? 1-3年占比最多占35%,其次是不限占33%. Where are the job locations at Tianqin Bio? 武汉占比最多占95.9%,其次是苏州占1.5%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 9,787.5617万(元)
Legal Representative: 任习东
Date Established:
Credit Code: 91420100685441393K
Registered Address: 武汉市东湖新技术开发区高新二路388号武汉光谷国际生物医药企业加速器1.2期27栋2层1室

Partners & Suppliers

天勤生物为海特生物提供药物非临床安全性评价服务 Source
合作客户 非临床安全性评价
天勤生物为人福医药创新药提供毒理研究服务 Source
合作客户 非临床安全性评价
天勤生物为友芝友生物提供抗体药物非临床评价服务 Source
合作客户 非临床安全性评价

People who follow Tianqin Bio also follow

Tianqin Bio Competitors (Similar Companies)

“Trustworthy biological experiment service provider”
“Global customized services for biological reagents”
“Leading enterprise in Hubei pharmaceutical industry, one of China's to”
“A technology-driven international pharmaceutical enterprise”
医药服务 生物制品 生物医药 疫苗
医药 生物制品 生物医药
制药/药业 医药 功能食品 牛磺酸
细胞病理 医学检验所 医学诊断 临床医学
“A large private modern pharmaceutical distribution enterprise in China”
生物医药 科学研究 试剂 检测试剂盒
生殖健康 生产 药物制剂 优生优育
医药 制药/药业 创新药 药物研发
口腔医院 医院 医疗护理 牙科医院
医药 生产 医药科技 医药工业
试剂 生命科学 生命科学研究 科学研究

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates